Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus

Endocrine Journal

Volumn 43, Issue 2, 1996, Pages 233-239

  Tojo, Chisa ^a   Takao, Toshihiro ^a   Nishioka, Tatsuya ^a   Numata, Yukiko ^a   Suemaru, Shuso ^b   Hashimoto, Kozo ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Fukuyama Municipal Hospital   (Japan)

Author keywords

ACTH; Corticosterone; Corticotropin releasing factor (CRF); Diabetes mellitus; Hypothalamic pituitary adrenal (HPA) axis

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 0029905403     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.233     Document Type: Article

References (28)

1. Scribner KA, Akana SF, Walker CD, Dallman MF (1993) Streptozotocin-diabetic rats exhibit facilitated adrenocorticotropin responses to acute stress, but normal sensitivity to feedback by corticosteroids. Endocrinology 133: 2667-2674.
2. L'age M, Jangholz J, Fechner W, Salzmann H (1974) Disturbances of the hypothalamo-hypophysial-adrenocortical system in the alloxan diabetic rat. Endocrinology 95: 760-765.
3. Gibson MJ, DeNicola AF, Krieger DT (1985) Streptozotocin-induced diabetes is associated with reduced immunoreactive beta-endorphin concentration in neurointermediate pituitary lobe and with disrupted circadian periodicity of plasma corticosterone levels. Neuroendocrinology 41: 64-71.
4. Taylor PK, Dawson G, Sadikario S (1983) The effect of streptozotocin-induced diabetes on pituitary and hypothalamic endorphin equivalents. Life Sci 32: 1935-1942.
5. Koizumi M, Toyota T, Goto Y (1989) WBN/Kob rats, a diabetic strain of rat with exocrine pancreatic insufficiency. Diabetes J 17: 51-60.
6. Hashimoto K, Hattori T, Murakami K, Suemaru S, Kawada Y, Kageyama J, Ota Z (1985) Reduction in brain immunoreactive corticorropin releasing factor (CRF) in spontaneously hypertensive rats. Life Sci 36: 643-647.
7. Nishioka T, Iyota K, Nakayama T, Suemaru S, Numata Y, Hashimoto K (1993) Effects of etherlaparotomy and water immersion-restraint stress on CRH concentration in the hypothalamus, extrahypothalamic tissues and peripheral blood. Endocrine J 40: 213-220.
8. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Anderson C, Nemeroff CB (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6: 2908-2914.
9. Hauger RL, Millaan MA, Lorang M, Harwood JP, Aguilera G (1988) Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress. Endocrinology 123: 396-405.
10. Hauger RL, Aguilera G (1993) Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: Interaction with vasopressin. Endocrinology 133: 1708-1714.
11. Tizabi Y, Aguilera G (1992) Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin. Neuroendocrinology 56: 611-618.
12. Hashimoto K, Murakami K, Hattori T, Niimi M, Fujino K, Ota Z (1984) Corticotropin(CRF)-like immunoreactivity in the adrenal medulla. Peptides 5: 707-711.
13. Suda T, Tomori N, Tozawa F, Mouri T, Demura H, Shizume K (1984) Distribution of immunoreactive corticotropin-releasing factor in human tissues. J Clin Endocrinol Metab 55: 861-866.
14. Brooks DP, Nutting DF, Crofton JT, Share L (1989) Vasopressin in rats with genetic and streptozotocin-induced diabetes. Diabetes 38: 54-57.
15. Antoni FA (1986) Hypothalamic control of adreno-corticotropin secretion: Advances since the discovery of 41-residue CRF. Endocrinol Rev 7: 351-378.
16. Plotsky PM (1987) Regulation of hypophysiotropic factors mediating ACTH secretion. Ann New York Acad Sci 512: 205.
17. Whitnall MH (1989) Stress selectivity activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. Neuroendocrinology 50: 702-707.
18. Gillies GE, Linton EA, Lowry PF (1982) Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299: 355-357.
19. Abou-Samra A-B, Harwood JP, Catt KJ, Aguilera G (1987) Mechanisms of action of CRH and other regulators of ACTH release in pituitary corticotrophs. Ann New York Acad Sci 512: 67-84.
20. Rivier C, Vale W (1983) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305: 325-327.
21. Gillies G, Lowry P (1979) Corticotropin releasing factor may be modulated by vasopressin. Nature 278: 463-464.
22. Scribner KA, Walker C-D, Cascio CS, Dallman MF (1991) Chronic streptozotocin diadetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 129: 99-108.
23. Lentle BC, Thomas JP (1964) Adrenal function and the complications of diabetes mellitus. The Lancet 544-549.
24. Roy M, Collier B, Roy A (1990) Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychi Res 31: 31-37.
25. Kimura M, Hiiooka Y, Mitsuma T, Nogimori T (1992) Study on the secretion of ACTH, β-endorphin-like-immunoreactivity and cortisol levels in non-insulin dependent diabetes mellitus. Prog 9th Int Cong Endocr, Nice, France 396 (Abstract).
26. Lu J, Li J, Pan C, Lu S, Ma S, Guo A (1988) Changes of pituitary-adrenal function in diabetics and their response to aminoglutethimide. Chin Med J 101: 587-590.
27. Tsigos C, Young RJ, White A (1993) Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 76: 554-558.
28. Hashimoto K, Nishioka T, Takao T, Numata Y (1993) Low plasma corticotropin-releasing hormone (CRH) levels in patients with non-insulin dependent diabetes mellitus (NIDDM). Endocrine J 40: 705-709.